Search

everythinglearnresearchcommunity

for

Search:↓

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Gut flora changes could potentially indicate depression, but more research is needed.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Non-coding RNAs could help detect and treat radiation damage.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Alligator pepper seed extract improved wound healing in rats.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Recent advances in hair loss treatments show significant progress.